Literature DB >> 20447884

Obesity and diabetes: the links and common approaches.

David Haslam1.   

Abstract

The term "diabesity" was famously coined by Sims and colleagues in the 1970s, to highlight the close relationship between type 2 diabetes and obesity. His team demonstrated that young men with no family history of diabetes when overfed for 6 months underwent a BMI increase to 28.0kg/m(2) alongside reversible rises in levels of fasting insulin, glucose, and triglycerides, and impaired glucose tolerance. Around 90% of type 2 diabetic patients have a BMI greater than 23.0kg/m(2), the risk of diabetes being greatly increased by a family history of diabetes or gestational diabetes, and early weight gain, especially in childhood. Patients with T2DM with co-existing obesity, can potentially be offered sub-optimum treatment at various points in the progression of their illness, unless the Primary healthcare team simultaneously embraces state-of-the-art methods within the fields of both diabetes and obesity. Obese individuals may be victims of inadequate screening, denying the chance of crucial early treatment, they may be left to languish at suboptimal HbA1c, they may be prescribed drugs which induce weight gain, whilst already being obese, vulnerable individuals may be given drugs which induce hypoglycaemia - often guideline and QOF led - and ultimately they may be converted to insulin before preferable alternatives have been explored. There have been many recent advances in both the fields of diabetes and obesity and it is important for clinicians to be aware of and familiar with newer interventions in both areas, as best practice and best outcomes are not achieved in their absence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447884     DOI: 10.1016/j.pcd.2010.04.002

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  9 in total

Review 1.  A review on interplay between obesity, lipoprotein profile and nutrigenetics with selected candidate marker genes of type 2 diabetes mellitus.

Authors:  Mustansir Bhori; Varuni Rastogi; Kanchanlata Tungare; Thankamani Marar
Journal:  Mol Biol Rep       Date:  2021-10-20       Impact factor: 2.316

2.  Impact of obesity on long-term survival after aortic valve replacement with a small prosthesis.

Authors:  Biao Wang; Hongyang Yang; Tao Wang; Xiquan Zhang; Wenjie Zhu; Guangqing Cao; Shuming Wu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-25

3.  Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer.

Authors:  Victoria Forte; Abhishek Pandey; Rita Abdelmessih; Giovanna Forte; Adam Whaley-Connell; James R Sowers; Samy I McFarlane
Journal:  Cardiorenal Med       Date:  2012-04-18       Impact factor: 2.041

4.  Obesity and the risk of late mortality after aortic valve replacement with small prosthesis.

Authors:  Biao Wang; Hongyang Yang; Shuming Wu; Guangqing Cao; Hongling Yang
Journal:  J Cardiothorac Surg       Date:  2013-07-15       Impact factor: 1.637

5.  Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms.

Authors:  Rebecca E Haddock; T Hilton Grayson; Margaret J Morris; Lauren Howitt; Preet S Chadha; Shaun L Sandow
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

6.  Health care professionals meeting with individuals with Type 2 diabetes and obesity: Balancing coaching and caution.

Authors:  Irene Svenningsson; Lillemor R-M Hallberg; Birgitta Gedda
Journal:  Int J Qual Stud Health Well-being       Date:  2011-06-29

7.  Sociodemographic factors associated with HbA1c variability in type 2 diabetes: a prospective exploratory cohort study.

Authors:  Emelia Mellergård; Per Johnsson; Frida Eek
Journal:  BMC Endocr Disord       Date:  2020-07-08       Impact factor: 2.763

8.  Beta-Glucan-Rich Extract from Pleurotus sajor-caju (Fr.) Singer Prevents Obesity and Oxidative Stress in C57BL/6J Mice Fed on a High-Fat Diet.

Authors:  G Kanagasabapathy; S N A Malek; A A Mahmood; K H Chua; S Vikineswary; U R Kuppusamy
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-07       Impact factor: 2.629

9.  TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity.

Authors:  Shitalkumar P Zambad; Davinder Tuli; Anoop Mathur; Sameer A Ghalsasi; Anita R Chaudhary; Shailesh Deshpande; Ramesh C Gupta; Vijay Chauthaiwale; Chaitanya Dutt
Journal:  Diabetes Metab Syndr Obes       Date:  2013-12-21       Impact factor: 3.168

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.